| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |